Skip to main content
Sister Publication Links
  • Middle East Foam & Polyurethane
  • UTECH Asia/PU China
  • UTECH Europe
  • UTECH Las Americas
Subscribe
  • My Account
  • Login
  • Subscribe
  • Ukraine
  • News
    • Asia
    • Americas
    • Europe
    • M & A
    • Financial results
    • Automotive
  • Data
  • Information
    • Country Overview
    • Market Sector overviews
    • Technical articles
    • Company profiles and strategies
  • Events
    • Exhibitions
    • Conferences
    • Webinars / Livestreams
    • Become a Speaker
  • Advertise
  • Contact Us
  • Issues
  • Subscribe
MENU
Breadcrumb
  1. Home
  2. News
May 19, 2011 12:00 AM

Biomerix in distribution agreement with Cellon

Utech Staff
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print

    Fremont, California -- Biomerix Corp. and Cellon SA have signed a distribution agreement under which Cellon will market and distribute the Biomerix 3D Scaffold, a novel three-dimensional tissue scaffold, to research institutions across Europe.

    The Biomerix 3D Scaffold is a non-degradable, three-dimensional, open-cell polycarbonate polyurethane, and is designed, said the company, "to mimic the nature and function of the extracellular matrix (ECM)."

    The material's "novel macroporous microarchitecture consists of a network of interconnecting cells and pores." According the Biomrerix, this creates "an environment highly conducive to applications in regenerative medicine, drug discovery, and stem cell research."

    Noting that the partnership strengthens each company's European presence in regenerative medicine, tissue engineering, and in drug discovery, development and delivery, Kenneth Hayes, president and ceo of Biomerix, said the biomaterial used in the scaffold has ???seven US and international regulatory clearances for different indications in soft tissue repair, orthopedics, and vascular embolisation."

    According to the company, the unique chemistry and microarchitecture of the 3D Scaffold has been shown to support optimal cell proliferation and superior cell viability in both in-vitro and in-vivo studies involving diverse cell types.
    "

    Recommended for You
    Foamer Eagle Industries issues Warn notice of potential layoffs
    Foamer Eagle Industries issues Warn notice of potential layoffs
    NKE24Q1
    Nike reports increased revenues, but margin down
    Omar Hoek CEO The Vita Group
    Hoek replaces Robb as CEO of The Vita Group
    Latest Issue
    urethanes technology
    Get the latest edition here
    View All Archives
    Get our newsletters

    Breaking news and in-depth coverage of essential topics delivered straight to your inbox.

    Subscribe today

    Register to access our archive of leading information on the polyurethanes industry.

    Subscribe now
    Connect with Us
    • Twitter
    • LinkedIn
    • Facebook
    • Youtube

    Follow us on social media for the latest polyurethanes industry news and event updates.

    Logo
    Contact Us

    Crain Communications
    11, Ironmonger Lane
    London
    EC2V 8EY
    United Kingdom

    Editorial
    Phone +44 (0) 20 3287 5935
    Email click to send

    Customer Service
    Phone +1 313 446 0450
    Email click to send

    Resources
    • Advertise with Us
    • Media Kit
    • Staff
    • Careers
    • Ad Choices
    • Sitemap
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • Ukraine
    • News
      • Asia
      • Americas
      • Europe
      • M & A
      • Financial results
      • Automotive
    • Data
    • Information
      • Country Overview
      • Market Sector overviews
      • Technical articles
      • Company profiles and strategies
    • Events
      • Exhibitions
      • Conferences
      • Webinars / Livestreams
      • Become a Speaker
    • Advertise
    • Contact Us
    • Issues
    • Subscribe